At close: December 13 at 3:58:18 PM EST
Breakdown
TTM
12/31/2021
12/31/2020
12/31/2019
Total Revenue
1,529,003.00
1,503,037.00
1,502,700.00
1,632,611.00
Cost of Revenue
874,015.00
883,472.00
937,005.00
1,022,324.00
Gross Profit
654,988.00
619,565.00
565,695.00
610,287.00
Operating Expense
583,362.00
530,594.00
621,606.00
673,439.00
Operating Income
71,626.00
88,971.00
-55,911.00
-63,152.00
Net Non Operating Interest Income Expense
-8,726.00
-13,166.00
-34,104.00
-43,172.00
Other Income Expense
59,269.00
86,021.00
-59,296.00
-175,427.00
Pretax Income
122,169.00
161,826.00
-149,311.00
-281,751.00
Tax Provision
6,255.00
27,851.00
-16,692.00
-43,340.00
Net Income Common Stockholders
60,634.00
134,438.00
700,407.00
-182,178.00
Diluted NI Available to Com Stockholders
60,634.00
134,438.00
700,407.00
-182,178.00
Basic EPS
0.45
1.03
4.40
-1.10
Diluted EPS
0.41
0.97
4.40
-1.10
Basic Average Shares
115,066.50
130,100.00
159,281.00
166,300.00
Diluted Average Shares
132,807.25
138,700.00
159,281.00
166,300.00
Total Operating Income as Reported
60,385.00
77,199.00
-130,880.00
-99,689.00
Total Expenses
1,457,377.00
1,414,066.00
1,558,611.00
1,695,763.00
Net Income from Continuing & Discontinued Operation
60,634.00
134,438.00
700,407.00
-182,178.00
Normalized Income
126,572.82
136,791.86
-64,647.93
-206,525.95
Interest Expense
8,726.00
13,166.00
34,104.00
43,172.00
Net Interest Income
-8,726.00
-13,166.00
-34,104.00
-43,172.00
EBIT
130,895.00
174,992.00
-115,207.00
-238,579.00
EBITDA
300,268.00
351,129.00
77,062.00
-40,353.00
Reconciled Cost of Revenue
727,309.00
730,444.00
770,340.00
851,286.00
Reconciled Depreciation
169,373.00
176,137.00
192,269.00
198,226.00
Net Income from Continuing Operation Net Minority Interest
115,914.00
133,975.00
-132,619.00
-237,987.00
Total Unusual Items Excluding Goodwill
-11,234.00
-3,402.00
-76,544.00
-37,188.00
Total Unusual Items
-11,234.00
-3,402.00
-76,544.00
-37,188.00
Normalized EBITDA
311,502.00
354,531.00
153,606.00
-3,165.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-575.18
-585.14
-8,572.93
-5,726.95
12/31/2019 - 7/26/1999
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CARA.ST Carasent AB (publ)
21.90
+1.86%
BMT.AX Beamtree Holdings Limited
0.2800
0.00%
GPI.MI GPI S.p.A.
10.50
+0.77%
EMOR Healixa Inc.
0.0600
0.00%
OMDA.OL Omda AS
28.50
-1.72%
RAY-B.ST RaySearch Laboratories AB (publ)
207.50
+2.22%
STRM Streamline Health Solutions, Inc.
3.5000
+0.57%
0MSD.IL CompuGroup Medical SE & Co. KGaA
16.22
0.00%
NRC National Research Corporation
17.79
-3.68%
SY So-Young International Inc.
0.8000
0.00%